LongevityResearch Phase

Epithalon (Epitalon)

Subcutaneous injection, Intravenous

Overview

A synthetic tetrapeptide (Ala-Glu-Asp-Gly) based on the natural epithalamin peptide produced by the pineal gland. Epithalon activates telomerase, the enzyme responsible for maintaining telomere length, thereby potentially extending cellular replicative capacity.

Mechanism of Action

It also stimulates melatonin production and modulates neuroendocrine system function associated with aging..

Research Summary & Key Findings

Studies by Khavinson et al. demonstrated telomerase activation in human somatic cells and elongation of telomeres. Rodent studies showed increased lifespan by 13-25%. Clinical observations in elderly patients suggested improvements in melatonin production and immune function biomarkers.

Clinical Status

Research Phase

Epithalon (Epitalon) is in the research phase with limited clinical data in humans. Current evidence is primarily derived from preclinical (animal or in vitro) studies.

Administration Routes

Subcutaneous injectionIntravenous

Related Peptides in Longevity

Find a Provider

Find a verified provider who offers Epithalon (Epitalon) therapy in your area.

Browse Provider Map

Find a Pharmacy

Browse PCAB-accredited and FDA 503B-registered compounding pharmacies that supply Epithalon (Epitalon).

Pharmacy Directory

Join the Association

Access exclusive peptide protocols, provider resources, and community support.

List Your Practice

Disclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol.